Régulation des réponses immunitaires
>> Publications
Allard B, Priam F, Deshayes F, Ducancel F, Boquet D, Wijkhuisen A, Couraud JY. Electroporation-Aided DNA Immunization Generates Polyclonal Antibodies Against the Native Conformation of Human Endothelin B Receptor. DNA Cell Biol. 2011 Jun 20. [Epub ahead of print]
Abstract
Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F (2011). Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro. Pigment Cell Melanoma Res. 2011 Jun;24(3):504-11.
Abstract
I. Martins, K. Sylla , F. Deshayes, J. Lauriol, M.C. Dieu-Nosjean, M. Viguier, O. Verola, D. Charron, R. Al-Daccak, et C. Alcaide-Loridan (2009). Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Mel. Res. 19 : 226-237.
Abstract
G. Badr, G. Borhis, E.A. Lefevre, N. Chaoul, F. Deshayes, V. Dessirier, G. Lapree, A. Tsapis et Y. Richard (2008). BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111 : 2744-2754
Abstract
N. Chetoui, K. Sylla, J.V. Gagnon-Houde, C. Alcaide-Loridan, D. Charron, R. Al-Daccak, et F. Aoudjit (2008). Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Mol. Cancer Res. 6 : 42-52.
Abstract
J.M. Doisne, J.G. Castaigne, C. Deruyffelaere, M.C. Dieu-Nosjean, C. Chamot, C. Alcaide-Loridan, D. Charron, et R. Al-Daccak (2008). The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes. Mol Immunol. 45 : 709-718.
Abstract
I. Martins, F. Deshayes, F. Baton, A. Forget, I. Ciechomska, K. Sylla, F. Aoudjit, D. Charron, R. Al-Daccak, et C. Alcaide-Loridan (2007). Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. Eur J Immunol 37:788-797.
Abstract
Defective Class II Transactivator (CIITA) expression in a B lymphoma cell line.
T. Prod'homme, B. Drénou, C. De Ruyffelaere, G. Barbieri, W. Wiszniewski, D. Charron, et C. Alcaide-Loridan (2004).
Leukemia, 18 : 832-840.
abstract
HLA-DR signaling inhibits Fas-mediated apoptosis in melanoma cells.
F. Aoudjit, W. Guo, J.G. Castaigne, C. Alcaide-Loridan, D. Charron, et R. Al-Daccak (2004).
Exp. Cell. Res. 299 : 79-90.
abstract
Isoforms of the Class II Transactivator Protein. Int.
G. Barbieri, V. Deffrennes, T. Prod'homme, J. Vedrenne, F. Baton, C. Cortes, A. Fischer, M.R. Bono, B. Lisowska-Grospierre, D. Charron et C. Alcaïde-Loridan (2002).
Immunol., 14 : 839-848.
abstract
Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency.
A.M. Lennon-Duménil, M.R. Barbouche, J. Vedrenne, T. Prod'homme, M. Béjaoui, S. Ghariani, D. Charron, M. Fellous, K. Dellagi et C. Alcaïde-Loridan (2001).
J. Immunol, 166 : 5681-5687.
abstract
Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
V. Deffrennes, J. Vedrenne, M.-C. Stolzenberg, J. Piskurich, G. Barbieri, J. P. Ting, D. Charron et C. Alcaïde-Loridan (2001).
J. Immunol., 167 : 98-106.
abstract
Dernière modification 27/06/2011